APA način citiranja

Kabootari, M., Hasheminia, M., Azizi, F., Mirbolouk, M., & Hadaegh, F. (2020). Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study. Cardiovasc Diabetol.

Čikaški stil citiranja

Kabootari, Maryam, Mitra Hasheminia, Fereidoun Azizi, Mohammadhassan Mirbolouk, i Farzad Hadaegh. "Change in Glucose Intolerance Status and Risk of Incident Cardiovascular Disease: Tehran Lipid and Glucose Study." Cardiovasc Diabetol 2020.

MLA način citiranja

Kabootari, Maryam, et al. "Change in Glucose Intolerance Status and Risk of Incident Cardiovascular Disease: Tehran Lipid and Glucose Study." Cardiovasc Diabetol 2020.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.